Glossary of terms
Bacteria which, having been stained with a dye, retain their colour in acid alcohol. Used as a technique for microscopic detection of mycobacteria.
Systematically identifying people with active or latent TB using tests, examinations or other procedures.
European Conformity (Conformité Européenne)-in vitro diagnosti
An economic study design in which consequences of different interventions are measured using a single outcome, usually in natural units (e.g. life-years gained, cases detected, deaths averted).
Disability-Adjusted Life Year
drug susceptibility testing
extrapulmonary TB - active TB disease in any site other than the lungs or tracheobronchial tree
external quality assessment
fluoroquinolones, a collective term for a set of second-line TB drugs
Grading of recommendations, assessment, development and evaluation
high burden country
Incremental cost-effectiveness ratio, a measure of the additional cost of a health care activity per unit of benefit (usually a QALY)
Low- and middle-income country
multidrug resistant TB, TB that is resistant to isoniazid and rifampin
nucleic acid amplification test
National TB Programme
point of care
Quality adjusted life year, an index of survival that is adjusted to account for the person’s quality of life during this time. QALYs incorporate changes in both quantity and quality of life.
Randomised controlled trial, a comparative study in which participants are randomly allocated to intervention and control groups, and prospectively followed up to examine differences in outcomes between the groups.
rapid diagnostic test
An accepted standard, for example for a test, against which other interventions can be compared.
second-line injectable drug
Supranational Reference Laboratory
sputum smear microscopy
Target Product Profile
extensively drug resistant TB